Profit Or Loss [Abstract]

Innate Pharma - Filing #2816890

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
24 703 EUR
69 773 EUR
Profit (loss) from operating activities
47 825 EUR
1 079 EUR
Finance income
6 344 EUR
4 855 EUR
Finance costs
3 997 EUR
6 763 EUR
Profit (loss) before tax
45 478 EUR
829,000 EUR
Tax expense (income)
EUR
EUR
Profit (loss) from continuing operations
45 478 EUR
829,000 EUR
Profit (loss) from discontinued operations
7 331 EUR
63 155 EUR
Profit (loss)
52 809 EUR
52 809 EUR
63 984 EUR
63 984 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
57.00
1.00
Basic earnings (loss) per share from discontinued operations
9.00
80.00
Basic earnings (loss) per share
66.00
81.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
57.00
1.00
Diluted earnings (loss) per share from discontinued operations
9.00
80.00
Diluted earnings (loss) per share
66.00
81.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.